GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$92.09 -0.43 (-0.46%)

Closing price 02/20/2025 04:00 PM Eastern

Extended Trading

$92.35 +0.26 (+0.28%)

As of 07:03 AM Eastern

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
1

Hold
3

Buy
9

Based on 13 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 1 has given a sell rating, 3 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$97.67
6.06% Upside

According to the 13 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $97.67. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $74.00. The average price target represents a forecasted upside of 6.06% from the current price of $92.09.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

GEHC Analyst Ratings Over Time

Type	Current Forecast 2/22/24 to 2/21/25	1 Month Ago 1/23/24 to 1/22/25	3 Months Ago 11/24/23 to 11/23/24	1 Year Ago 2/22/23 to 2/22/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$97.67	$96.00	$94.36	$88.83
Forecasted Upside	6.06% Upside	9.93% Upside	14.46% Upside	1.36% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.69	2.82	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	6.06% Upside	28,670.83% Upside	12.83% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/14/2025	Wells Fargo & Company 3 of 5 stars	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$96.00 ➝ $103.00	+11.79%
2/13/2025	Citigroup 3 of 5 stars	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$103.00 ➝ $110.00	+17.67%
1/8/2025	Jefferies Financial Group 2 of 5 stars		Upgrade	Hold ➝ Buy	$95.00 ➝ $103.00	+23.55%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$98.00 ➝ $102.00	+10.82%
9/30/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $102.00	+10.88%
9/26/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Doyle Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$84.00 ➝ $74.00	-20.44%
9/18/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00	+15.22%
9/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$90.00	+5.77%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$87.00	+10.90%
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
5/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$94.00 ➝ $86.00	+10.45%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$110.00 ➝ $105.00	+35.45%
4/1/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $110.00	+22.82%
2/15/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.24%
2/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$74.00 ➝ $86.00	+3.40%
5/15/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$97.00	+29.45%
4/19/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$95.00	+13.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:20 AM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, February 16, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

Recent upgrades from multiple analysts, including Citigroup raising the price target to $110.00, indicate strong market confidence in the stock's potential for growth.
The stock currently trades at $92.21, which is below the consensus price target of approximately $97.67, suggesting potential for price appreciation.
GE HealthCare Technologies Inc. reported a quarterly earnings per share (EPS) of $1.45, exceeding analysts' expectations, which reflects strong operational performance.
The company has a solid return on equity of 25.19%, indicating effective management and profitability relative to shareholder equity.
Institutional investors own 82.06% of the company's stock, which often signals confidence in the company's long-term prospects and stability.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

Despite recent positive earnings, the company had revenue of $5.32 billion, slightly below analyst estimates, which may raise concerns about future growth potential.
The stock has a relatively high P/E ratio of 25.33, which could indicate that it is overvalued compared to its earnings, making it a riskier investment.
GE HealthCare Technologies Inc. has a debt-to-equity ratio of 1.12, suggesting that the company has a significant amount of debt compared to its equity, which could pose risks in economic downturns.
One analyst has rated the stock with a sell rating, indicating that there are differing opinions on the stock's future performance.
The stock's recent trading volume was significantly higher than its average, which could indicate volatility and uncertainty in the market.

GEHC Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $97.67, with a high forecast of $110.00 and a low forecast of $74.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There is currently 1 sell rating, 3 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.
: According to analysts, GE HealthCare Technologies's stock has a predicted upside of 6.06% based on their 12-month stock forecasts.
: Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade by analysts.
: GE HealthCare Technologies has been rated by research analysts at Citigroup, Jefferies Financial Group, and Wells Fargo & Company in the past 90 days.
: Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.69 while the average consensus rating score for "medical" companies is 2.82. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:GEHC) was last updated on 2/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target